Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate Cancer.

Sayegh N; Ozay ZI; Zhang T; Agarwal N

doi:10.1200/JCO-25-01009

← 뒤로

Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025 Vol.43(28) p. 3057-3060

Sayegh N, Ozay ZI, Zhang T, Agarwal N

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Sayegh N, Ozay ZI, et al. (2025). Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(28), 3057-3060. https://doi.org/10.1200/JCO-25-01009

MLA Sayegh N, et al.. "Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate Cancer.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 43, no. 28, 2025, pp. 3057-3060.

PMID 40720739

DOI 10.1200/JCO-25-01009

같은 제1저자의 인용 많은 논문 (1)

Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2026